GAMA
BNTX icon

Graticule Asia Macro Advisors’s BioNTech BNTX Stock Holding History

Graticule Asia Macro Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-38,650
Closed -$2.58M – 86
2020
Q2 		$2.58M Buy
+38,650
New +$1.93M 0.3% 20

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Graticule Asia Macro Advisors's BNTX Position: Q3 2020 in Review

Graticule Asia Macro Advisors sold out of BioNTech (BNTX) in Q3 2020, closing a stake of 38,650 shares — an estimated $2.58M sold.

Graticule Asia Macro Advisors first reported a position in BNTX in Q2 2020 and held it in 1 quarter. The position peaked at $2.58M in Q2 2020. 147 funds tracked by Wall St. Rank hold BNTX as of Q3 2020.

  • Graticule Asia Macro Advisors reported no remaining BioNTech position as of Q3 2020 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 38,650 BioNTech shares in Q3 2020, an estimated $2.58M.
  • Graticule Asia Macro Advisors first reported a position in BioNTech in Q2 2020 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's BioNTech position peaked at $2.58M in Q2 2020.
  • 147 funds tracked by Wall St. Rank held BioNTech as of Q3 2020.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.